[IF=2.98] Sui et al. Antitumor effect of a selective COX-2 inhibitor, celecoxib, may be attributed to angiogenesis inhibition through modulating the PTEN/PI3K/Akt/HIF-1 pathway in an H₂₂ murine hepatocarcinoma model. (2014) Oncol.Rep. 31:2252-60 IHC ; Mouse.